LINCR Activators are a diverse array of chemical compounds that indirectly boost the functional activity of LINCR through modulation of various cellular signaling pathways and gene regulatory mechanisms. Forskolin, PMA, and Sphingosine-1-phosphate engage in enhancing the activity of kinases like PKA and PKC or through G-protein coupled receptors, which subsequently can influence the regulatory roles played by LINCR in gene expression. For instance, Forskolin increases cAMP levels, thereby activating PKA, which could phosphorylate transcription factors that modulate LINCR's activity. PMA's activation of PKC and Sphingosine-1-phosphate's involvement in sphingolipid signaling could similarly lead to enhanced functional roles of LINCR by impacting the regulatory networks in which it operates. Moreover, the action of Epigallocatechin gallate (EGCG) as a kinase inhibitor, along with the PI3K inhibitors LY294002 and Wortmannin, serves to downregulate competitive signaling pathways, potentially shifting the balance towards mechanisms that favor LINCR activity.
Further modulation of LINCR activity is achieved through chemicals that affect gene expression and epigenetics. 5-Azacytidine, by inhibiting DNA methyltransferase, and retinoic acid, through its action on retinoid receptors, can alter the epigenetic landscape and gene expression profiles, potentially leading to an upregulated LINCR activity. Similarly, HDAC inhibitors such as SodiumButyrate and Trichostatin A can increase histone acetylation, which may result in a more open chromatin conformation, thereby facilitating the enhanced activity of LINCR by influencing the transcriptional machinery. Additionally, Genistein's inhibition of tyrosine kinase signaling could remove competitive inhibition mechanisms, allowing LINCR to exert greater influence over gene regulatory networks. A23187's elevation of intracellular calcium levels triggers calcium-dependent signaling pathways that might positively affect LINCR's activity. Collectively, these LINCR Activators, through their targeted effects on signal transduction, chromatin remodeling, and gene expression, converge to potentiate the role of LINCR in regulating gene networks without a need for upregulating its expression directly.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog which activates protein kinase C (PKC). Activation of PKC has been linked to modulation of non-coding RNA expression, potentially increasing the functional activity of LINCR. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG acts as an inhibitor of several protein kinases. By inhibiting competitive pathways, EGCG may favor signaling processes that upregulate the activity of LINCR. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of PI3K, leading to the suppression of the AKT pathway. Reduction of AKT activity could alter the cell's regulatory environment, indirectly enhancing LINCR's functional role in gene regulation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Similar to LY294002, Wortmannin is also a PI3K inhibitor. It could therefore contribute to an increase in LINCR's activity by indirectly influencing gene regulatory networks. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate is involved in the sphingolipid signaling pathway and can activate various kinases and G-protein coupled receptors, which may enhance signaling pathways where LINCR is implicated. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This chemical is a DNA methyltransferase inhibitor, which can lead to the demethylation and reactivation of genes. It could indirectly increase the activity of LINCR by altering the epigenetic landscape. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that may lead to the diversion of cellular pathways, enhancing the activity of non-coding RNAs like LINCR through reduction of competitive signal transduction. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can modulate gene expression via retinoid receptors. Its influence on gene regulatory networks could indirectly enhance the activity of LINCR by impacting gene expression profiles. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels, which can activate calcium-dependent signaling pathways. These pathways may positively influence the activity of LINCR. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is an HDAC inhibitor leading to hyperacetylation of histones, which can result in a more open chromatin structure and potentially higher activity of LINCR. | ||||||